139 related articles for article (PubMed ID: 3867028)
21. Localization of anti-osteogenic sarcoma monoclonal antibody 791T/36 in a primary human osteogenic sarcoma and its subsequent xenograft in immunodeprived mice.
Pimm MV; Perkins AC; Armitage NC; Baldwin RW
Cancer Immunol Immunother; 1985; 19(1):18-21. PubMed ID: 3856475
[TBL] [Abstract][Full Text] [Related]
22. [Use of radio-labelled monoclonal antibodies for the scintigraphic detection of human colorectal cancers].
Chatal JF; Bourdoiseau M; Fumoleau P; Douillard JY; Kremer M; Curtet C; Le Mevel B
Bull Cancer; 1983; 70(2):103-7. PubMed ID: 6871485
[TBL] [Abstract][Full Text] [Related]
23. Localisation of human osteosarcoma by antitumour monoclonal antibody.
Farrands PA; Perkins A; Sully L; Hopkins JS; Pimm MV; Baldwin RW; Hardcastle JD
J Bone Joint Surg Br; 1983 Nov; 65(5):638-40. PubMed ID: 6358231
[TBL] [Abstract][Full Text] [Related]
24. Dose escalation trial of indium-111-labeled anti-carcinoembryonic antigen chimeric monoclonal antibody (chimeric T84.66) in presurgical colorectal cancer patients.
Wong JY; Chu DZ; Yamauchi D; Odom-Maryon TL; Williams LE; Liu A; Esteban JM; Wu AM; Primus FJ; Beatty JD; Shively JE; Raubitschek AA
J Nucl Med; 1998 Dec; 39(12):2097-104. PubMed ID: 9867150
[TBL] [Abstract][Full Text] [Related]
25. Immunoscintigraphy of colorectal carcinoma with F (ab')2 fragments of anti-CEA monoclonal antibody.
Buraggi G; Callegaro L; Turrin A; Gennari L; Bombardieri E; Mariani G; Deleide G; Dovis M; Gasparini M; Doci R
Cancer Detect Prev; 1987; 10(5-6):335-45. PubMed ID: 3568032
[TBL] [Abstract][Full Text] [Related]
26. Tumor imaging of colo-rectal carcinoma with an anti-CEA monoclonal antibody.
Gasparini M; Ripamonti M; Seregni E; Regalia E; Buraggi GL
Int J Cancer Suppl; 1988; 2():81-4. PubMed ID: 3162449
[TBL] [Abstract][Full Text] [Related]
27. The characteristics of blood-borne radiolabels and the effect of anti-mouse IgG antibodies on localization of radiolabeled monoclonal antibody in cancer patients.
Pimm MV; Perkins AC; Armitage NC; Baldwin RW
J Nucl Med; 1985 Sep; 26(9):1011-23. PubMed ID: 3861794
[TBL] [Abstract][Full Text] [Related]
28. A new approach to image subtraction in immunoscintigraphy: preliminary results.
Liehn JC; Hannequin P; Nasca S; Lebrun D; Cattan A; Valeyre J
Eur J Nucl Med; 1987; 13(8):391-6. PubMed ID: 3325290
[TBL] [Abstract][Full Text] [Related]
29. Localization of radioiodinated monoclonal antibody in colorectal cancer. Initial dosimetry results.
Cohn KH; Welt S; Banner WP; Harrington M; Yeh S; Sakamoto J; Cardon-Cardo C; Daly J; Kemeny N; Cohen A
Arch Surg; 1987 Dec; 122(12):1425-9. PubMed ID: 3689120
[TBL] [Abstract][Full Text] [Related]
30. Recent advances in tumour imaging. Use of radiolabelled antitumour antibodies.
Begent RH
Biochim Biophys Acta; 1985; 780(2):151-66. PubMed ID: 2988609
[No Abstract] [Full Text] [Related]
31. Indium 111 ZCE-025 immunoscintigraphy in occult recurrent colorectal cancer with elevated carcinoembryonic antigen level.
Doerr RJ; Abdel-Nabi H; Merchant B
Arch Surg; 1990 Feb; 125(2):226-9. PubMed ID: 2302062
[TBL] [Abstract][Full Text] [Related]
32. Iodine-131 and indium-111 labelled avidin and streptavidin for pre-targetted immunoscintigraphy with biotinylated anti-tumour monoclonal antibody.
Pimm MV; Fells HF; Perkins AC; Baldwin RW
Nucl Med Commun; 1988 Nov; 9(11):931-41. PubMed ID: 3251178
[TBL] [Abstract][Full Text] [Related]
33. Localisation of metastatic carcinoma by a radiolabelled monoclonal antibody.
Smedley HM; Finan P; Lennox ES; Ritson A; Takei F; Wraight P; Sikora K
Br J Cancer; 1983 Feb; 47(2):253-9. PubMed ID: 6337613
[TBL] [Abstract][Full Text] [Related]
34. Colorectal tumors: scintigraphy with In-111 anti-CEA monoclonal antibody and correlation with surgical, histopathologic, and immunohistochemical findings.
Abdel-Nabi HH; Schwartz AN; Goldfogel G; Ortman-Nabi JA; Matsuoka DM; Unger MW; Wechter DG
Radiology; 1988 Mar; 166(3):747-52. PubMed ID: 3277244
[TBL] [Abstract][Full Text] [Related]
35. [Clinical application of radioimmunolocalization in colorectal cancer].
Germà JR; Alvarez I; Carrió I; Estorch M; Bernà L; Martínez-Duncker C; Marcuello E; Nogueras FM
Med Clin (Barc); 1990 Mar; 94(9):325-8. PubMed ID: 2329866
[TBL] [Abstract][Full Text] [Related]
36. Antibody distribution and dosimetry in patients receiving radiolabelled antibody therapy for colorectal cancer.
Begent RH; Ledermann JA; Green AJ; Bagshawe KD; Riggs SJ; Searle F; Keep PA; Adam T; Dale RG; Glaser MG
Br J Cancer; 1989 Sep; 60(3):406-12. PubMed ID: 2789951
[TBL] [Abstract][Full Text] [Related]
37. In-111 CYT-103 monoclonal antibody imaging in patients with suspected recurrent colorectal cancer.
Doerr RJ; Herrera L; Abdel-Nabi H
Cancer; 1993 Jun; 71(12 Suppl):4241-7. PubMed ID: 8508386
[TBL] [Abstract][Full Text] [Related]
38. Improved detection of hepatic lesions using MoAb B72.3 and a modified 111In labelling technique in patients with recurrent colon cancer.
Vijayakumar V; Blend MJ; Johnson DK; Seevers RH; Schnobrich KE; Bekerman C
Nucl Med Commun; 1993 Aug; 14(8):658-66. PubMed ID: 8371891
[TBL] [Abstract][Full Text] [Related]
39. Radiolabeled monoclonal antibody B72.3 localization in metastatic lesions of colorectal cancer patients.
Colcher D; Carrasquillo JA; Esteban JM; Sugarbaker P; Reynolds JC; Siler K; Bryant G; Larson SM; Schlom J
Int J Rad Appl Instrum B; 1987; 14(3):251-62. PubMed ID: 3667307
[TBL] [Abstract][Full Text] [Related]
40. Tumour visualisation using a radiolabelled monoclonal antibody.
Zalcberg JR; Thompson CH; Lichtenstein M; Leyden MJ; Andrews JT; Sullivan JR; McKenzie IF
Aust N Z J Med; 1983 Dec; 13(6):571-7. PubMed ID: 6326726
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
